Results 241 to 250 of about 174,305 (306)

Maternal Gestational Diabetes Impairs Fetoplacental Insulin-Induced Vasodilation via AKT/eNOS Pathway and Reduces Placental Efficiency. [PDF]

Int J Mol Sci
Hengst CM, Villar-Ballesteros ML, Brendel H, Giebe S, Brunssen C, Frühauf A, Birdir C, Taylor PD, Poston L, Morawietz H.   +9 more
europepmc   +1 more source

HomoTherm: An Open-Source Approach to Modelling Heat Exchange in Humans and Other Hominins in Diverse Environments. [PDF]

Glob Chang Biol
Kearney MR, Mitchell D, Maloney SK.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Vasodilators

Reactions Weekly, 2014
Abstract The vasodilator combination of hydralazine and isosorbide dinitrate may be considered as an alternative to an ACE inhibitor or ARB, if neither is tolerated, to reduce the risk of HF hospitalization and risk of premature death in patients with chronic heart failure secondary to LVSD. This chapter describes the pharmacology and
Roy S. Gardner, Theresa A. McDonagh, Niki L. Walker   +2 more
  +4 more sources

Vasodilator therapy

The American Journal of Medicine, 1986
Vasodilators are a group of drugs with various degrees of arteriolar or venous dilatation used in the treatment of congestive heart failure when symptoms persist after digoxin and diuretic therapy. Nitrates and captopril provide the most consistent improvement in symptoms. Reduced mortality rates in congestive heart failure with vasodilator therapy has
openaire   +2 more sources